Create a lasting legacy with the ultimate gift 3 September 2024 Diabetes Australia is at the forefront of supporting people living with all types of diabetes, providing essential support, services, education, and groundbreaking research. Our work is driven by an ambition for a future where diabetes can do no harm. Diabetes Australia members are at the heart of this, uniting with us to change lives and change the future for people living with all types of diabetes. As a valued member of Diabetes Australia, we want to share with you an opportunity to be part of Include a Charity Week, a social change campaign which aims to encourage more Australians to pledge a charitable gift in their will. During this week of September 2-8, you can write your will and secure your family’s future for free. If you’re interested in pledging a gift in your will, we are pleased to offer you a free and easy way to write your will via our partnership with Safewill, Australia’s most trusted online will platform. No matter the size of your gift, it will make a significant difference in the lives of people living with and at risk of diabetes. It’s a powerful way to ensure that your legacy has a positive, life-changing impact that keeps on giving. By including a gift to Diabetes Australia in your will, you can leave a lasting impact that will benefit generations to come. Your legacy will help fund crucial programs that provide life-changing support, enhance education and awareness, and drive research to discover better treatments and, ultimately, a cure. If you’ve had the chance to reflect on this opportunity, we encourage you to consider the profound impact your gift could have. Thank you for considering this meaningful way to extend your support and make a lasting difference
Blog 18 November 2026 Make a splash: Water exercise for diabetes As the weather warms up, it can be less enticing to go for that walk or bike ride, so why... Continue Reading
Media releases 18 November 2026 Foundayo approval a welcome addition to GLP-1 treatment options Diabetes Australia has welcomed the TGA approval of Foundayo (orforglipron), a new oral GLP-1 receptor agonist for the management of type 2 diabetes and chronic weight management in eligible adults. Continue Reading
Blog 18 November 2026 Five days of easier meal decisions Discover five days of realistic meal ideas designed to help you enjoy a variety of foods, save time in the kitchen, and make nutritious choices with less stress and planning. Continue Reading